Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.
Nakamura H, Taguchi A, Kawana K, Baba S, Kawata A, Yoshida M, Fujimoto A, Ogishima J, Sato M, Inoue T, Nishida H, Furuya H, Yamashita A, Eguchi S, Tomio K, Mori-Uchino M, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T.
Nakamura H, et al. Among authors: eguchi s.
Oncotarget. 2018 Feb 5;9(17):13451-13461. doi: 10.18632/oncotarget.24413. eCollection 2018 Mar 2.
Oncotarget. 2018.
PMID: 29568369
Free PMC article.